Tag: EVOKE trial

Saluda announces plans to present new EVOKE study data at NANS...

Saluda Medical has announced that its data will be presented at the upcoming North American Neuromodulation Society (NANS) annual meeting (18–21 January, Las Vegas,...

The new standard for SCS therapy—neural activation measurement, targeting and maintenance

Jason Pope (Santa Rosa, USA) discusses closed-loop spinal cord stimulation (SCS) and its potential to provide sustained, holistic outcomes for chronic pain patients. In...

Saluda Medical announces presentation of 36-month EVOKE trial data at NANS...

Saluda Medical has announced that late-breaking data from the "landmark" EVOKE clinical trial was presented at the recent North American Neuromodulation Society (NANS) annual...

Saluda announces sustained, long-term pain relief results with closed-loop SCS in...

Saluda Medical today announced long-term results from its double-blind, Level 1 EVOKE trial, which have been published in JAMA Neurology and demonstrate superior, sustained pain...